Website: 23andMe
Business Area(s):
Description:
Provides direct-to-consumer DNA testing services. Aug 2020, received 510(k) clearance from the US Food and Drug Administration for its CYP2C19 Drug Metabolism Report, which informs customers whether their genotypes may influence their ability to respond to clopidogrel and citalopram without the need for confirmatory testing.
Career Page(s):
Location(s):
Mountain View
CA
United States
See map: Google Maps